Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
ConclusionWe identified subgroups of women with breast cancer at increased risk of non-adherence. Our findings related to comorbidity suggest the importance of focusing on the presence of specific co-existing conditions when monitoring adherence.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Education | Heart Attack | Sweden Health | Tamoxifen | Women